{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:44:27Z","timestamp":1791690267441,"version":"4.3.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,4]],"date-time":"2020-01-04T00:00:00Z","timestamp":1578096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.gendis.2019.12.007","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T02:25:01Z","timestamp":1578450301000},"page":"146-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Promising therapeutic approaches using CRISPR\/Cas9 genome editing technology in the treatment of Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"8","author":[{"given":"Hasan","family":"Mollanoori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazdan","family":"Rahmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bita","family":"Hassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meysam","family":"Havasi Mehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8642-9128","authenticated-orcid":false,"given":"Shahram","family":"Teimourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.gendis.2019.12.007_bib1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5435\/00124635-200203000-00009","article-title":"Duchenne muscular dystrophy","volume":"10","author":"Sussman","year":"2002","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.gendis.2019.12.007_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cca.2019.01.014","article-title":"Molecular genetic testing and diagnosis strategies for dystrophinopathies in the era of next generation sequencing","volume":"491","author":"Zhang","year":"2019","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.gendis.2019.12.007_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-genom-090314-025003","article-title":"The pathogenesis and therapy of muscular dystrophies","volume":"16","author":"Guiraud","year":"2015","journal-title":"Annu Rev Genom Hum Genet"},{"key":"10.1016\/j.gendis.2019.12.007_bib4","article-title":"Molecular diagnosis of Duchenne muscular dystrophy","volume":"83","author":"Nallamilli","year":"2014","journal-title":"Curr Protoc Hum Genet"},{"issue":"8","key":"10.1016\/j.gendis.2019.12.007_bib5","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/01.RES.0000126574.61061.25","article-title":"The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma","volume":"94","author":"Lapidos","year":"2004","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.gendis.2019.12.007_bib6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/cr.2016.28","article-title":"Duchenne muscular dystrophy: CRISPR\/Cas9 treatment","volume":"26","author":"Mendell","year":"2016","journal-title":"Cell Res"},{"issue":"9","key":"10.1016\/j.gendis.2019.12.007_bib7","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1080\/00207454.2018.1430694","article-title":"Duchenne muscular dystrophy: an updated review of common available therapies","volume":"128","author":"Salmaninejad","year":"2018","journal-title":"Int J Neurosci"},{"issue":"6213","key":"10.1016\/j.gendis.2019.12.007_bib8","doi-asserted-by":"crossref","first-page":"e1258096","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.gendis.2019.12.007_bib9","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.humimm.2018.09.007","article-title":"CRISPR\/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment","volume":"79","author":"Mollanoori","year":"2018","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.gendis.2019.12.007_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10529-014-1656-5","article-title":"Technology developments in biological tools for targeted genome surgery","volume":"37","author":"Teimourian","year":"2015","journal-title":"Biotechnol Lett"},{"issue":"5","key":"10.1016\/j.gendis.2019.12.007_bib11","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.ymthe.2017.02.019","article-title":"Progress toward gene therapy for Duchenne muscular dystrophy","volume":"25","author":"Chamberlain","year":"2017","journal-title":"Mol Ther: J Am Soc Gene Ther"},{"issue":"4","key":"10.1016\/j.gendis.2019.12.007_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/humu.22758","article-title":"The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations","volume":"36","author":"Bladen","year":"2015","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.gendis.2019.12.007_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/wnan.1472","article-title":"Nanotherapy for Duchenne muscular dystrophy","volume":"10","author":"Nance","year":"2018","journal-title":"Wiley interdisciplinary Rev Nanomedicine Nanobiotechnol"},{"issue":"2","key":"10.1016\/j.gendis.2019.12.007_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/mus.20586","article-title":"Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule","volume":"34","author":"Aartsma-Rus","year":"2006","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.gendis.2019.12.007_bib15","first-page":"498","article-title":"The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion","volume":"45","author":"Koenig","year":"1989","journal-title":"Am J Hum Genet"},{"issue":"11","key":"10.1016\/j.gendis.2019.12.007_bib16","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/humu.22390","article-title":"The TREAT-NMD Duchenne muscular dystrophy registries: conception, design, and utilization by industry and academia","volume":"34","author":"Bladen","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.gendis.2019.12.007_bib17","series-title":"G.B.A. Duchenne de Boulogne (1806\u20131875)","author":"Rondot","year":"2005"},{"issue":"3","key":"10.1016\/j.gendis.2019.12.007_bib18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","article-title":"Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals","volume":"50","author":"Koenig","year":"1987","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.gendis.2019.12.007_bib19","first-page":"86","article-title":"Myodys, a full-length dystrophin plasmid vector for Duchenne and Becker muscular dystrophy gene therapy","volume":"10","author":"Duan","year":"2008","journal-title":"Curr Opin Mol Ther"},{"issue":"4949 Pt 1","key":"10.1016\/j.gendis.2019.12.007_bib20","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in\u00a0vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"issue":"6338","key":"10.1016\/j.gendis.2019.12.007_bib21","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/352815a0","article-title":"Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs","volume":"352","author":"Acsadi","year":"1991","journal-title":"Nature"},{"issue":"6254","key":"10.1016\/j.gendis.2019.12.007_bib22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/343180a0","article-title":"Very mild muscular dystrophy associated with the deletion of 46% of dystrophin","volume":"343","author":"England","year":"1990","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.gendis.2019.12.007_bib23","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1093\/hmg\/11.20.2355","article-title":"Gene therapy of muscular dystrophy","volume":"11","author":"Chamberlain","year":"2002","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.1016\/j.gendis.2019.12.007_bib24","first-page":"3148","article-title":"Introduction of rod-deleted dystrophin cDNA, delta DysM3, into mdx skeletal muscle using adenovirus vector","volume":"55","author":"Yuasa","year":"1997","journal-title":"Jpn J Clin Med"},{"issue":"8","key":"10.1016\/j.gendis.2019.12.007_bib25","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nm1085","article-title":"Systemic delivery of genes to striated muscles using adeno-associated viral vectors","volume":"10","author":"Gregorevic","year":"2004","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.gendis.2019.12.007_bib26","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1172\/JCI36612","article-title":"Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy","volume":"119","author":"Lai","year":"2009","journal-title":"J Clin Investig"},{"issue":"7","key":"10.1016\/j.gendis.2019.12.007_bib27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41582-019-0203-3","article-title":"Therapeutic developments for Duchenne muscular dystrophy","volume":"15","author":"Verhaart","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.gendis.2019.12.007_bib28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1073\/pnas.98.1.42","article-title":"Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse","volume":"98","author":"Mann","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"10.1016\/j.gendis.2019.12.007_bib29","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/hmg\/10.15.1547","article-title":"Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells","volume":"10","author":"van Deutekom","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.gendis.2019.12.007_bib30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1073\/pnas.0406700102","article-title":"Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles","volume":"102","author":"Lu","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.gendis.2019.12.007_bib31","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/mt.2013.246","article-title":"Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin alpha 2 surrogates","volume":"22","author":"Chicoine","year":"2014","journal-title":"Mol Ther: J Am Soc Gene Ther"},{"issue":"6","key":"10.1016\/j.gendis.2019.12.007_bib32","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s10529-018-2555-y","article-title":"Therapeutic applications of CRISPR\/Cas9 system in gene therapy","volume":"40","author":"Mollanoori","year":"2018","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.gendis.2019.12.007_bib33","doi-asserted-by":"crossref","first-page":"e14454","DOI":"10.1038\/ncomms14454","article-title":"Muscle-specific CRISPR\/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy","volume":"8","author":"Bengtsson","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.gendis.2019.12.007_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.omtn.2017.02.007","article-title":"CRISPR\/Cas9-Mediated genome editing corrects dystrophin mutation in skeletal muscle stem cells in a mouse model of muscle dystrophy","volume":"7","author":"Zhu","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6201","key":"10.1016\/j.gendis.2019.12.007_bib35","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.1254445","article-title":"Prevention of muscular dystrophy in mice by CRISPR\/Cas9\u2013mediated editing of germline DNA","volume":"345","author":"Long","year":"2014","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.gendis.2019.12.007_bib36","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41551-017-0137-2","article-title":"Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in\u00a0vivo induces homology-directed DNA repair","volume":"1","author":"Lee","year":"2017","journal-title":"Nat Biomed Eng"},{"issue":"11","key":"10.1016\/j.gendis.2019.12.007_bib37","doi-asserted-by":"crossref","first-page":"a012740","DOI":"10.1101\/cshperspect.a012740","article-title":"Repair of strand breaks by homologous recombination","volume":"5","author":"Jasin","year":"2013","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"3","key":"10.1016\/j.gendis.2019.12.007_bib38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/humu.20918","article-title":"Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations","volume":"30","author":"Aartsma-Rus","year":"2009","journal-title":"Hum Mutat"},{"issue":"6271","key":"10.1016\/j.gendis.2019.12.007_bib39","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","article-title":"In\u00a0vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"issue":"6271","key":"10.1016\/j.gendis.2019.12.007_bib40","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","article-title":"In\u00a0vivo gene editing in dystrophic mouse muscle and muscle stem cells","volume":"351","author":"Tabebordbar","year":"2016","journal-title":"Science"},{"issue":"6271","key":"10.1016\/j.gendis.2019.12.007_bib41","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","article-title":"Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy","volume":"351","author":"Long","year":"2016","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.gendis.2019.12.007_bib42","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/mt.2015.192","article-title":"CRISPR-mediated genome editing restores dystrophin expression and function in mdx mice","volume":"24","author":"Xu","year":"2016","journal-title":"Mol Ther: J Am Soc Gene Ther"},{"issue":"8","key":"10.1016\/j.gendis.2019.12.007_bib43","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCRESAHA.117.310996","article-title":"In\u00a0vivo genome editing restores dystrophin expression and cardiac function in dystrophic mice","volume":"121","author":"El Refaey","year":"2017","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.gendis.2019.12.007_bib44","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/jhg.2016.28","article-title":"Deletion of exons 3-9 encompassing a mutational hot spot in the DMD gene presents an asymptomatic phenotype, indicating a target region for multiexon skipping therapy","volume":"61","author":"Nakamura","year":"2016","journal-title":"J Hum Genet"},{"issue":"18","key":"10.1016\/j.gendis.2019.12.007_bib45","doi-asserted-by":"crossref","first-page":"e95918","DOI":"10.1172\/jci.insight.95918","article-title":"Functional correction of dystrophin actin binding domain mutations by genome editing","volume":"2","author":"Kyrychenko","year":"2017","journal-title":"JCI insight"},{"key":"10.1016\/j.gendis.2019.12.007_bib46","doi-asserted-by":"crossref","first-page":"e6244","DOI":"10.1038\/ncomms7244","article-title":"Multiplex CRISPR\/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy","volume":"6","author":"Ousterout","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.gendis.2019.12.007_bib47","doi-asserted-by":"crossref","first-page":"e17113","DOI":"10.1038\/s41598-017-17180-w","article-title":"CRISPR\/Cas9 delivery with one single adenoviral vector devoid of all viral genes","volume":"7","author":"Ehrke-Schulz","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.gendis.2019.12.007_bib48","doi-asserted-by":"crossref","first-page":"e37051","DOI":"10.1038\/srep37051","article-title":"Adenoviral vectors encoding CRISPR\/Cas9 multiplexes rescue dystrophin synthesis in unselected populations of DMD muscle cells","volume":"6","author":"Maggio","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.gendis.2019.12.007_bib49","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/nar\/gkv1540","article-title":"Selection-free gene repair after adenoviral vector transduction of designer nucleases: rescue of dystrophin synthesis in DMD muscle cell populations","volume":"44","author":"Maggio","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.gendis.2019.12.007_bib50","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3233\/JND-170218","article-title":"Creation of a novel humanized dystrophic mouse model of Duchenne muscular dystrophy and application of a CRISPR\/Cas9 gene editing therapy","volume":"4","author":"Young","year":"2017","journal-title":"J Neuromuscul Dis"},{"issue":"4","key":"10.1016\/j.gendis.2019.12.007_bib51","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","article-title":"A single CRISPR-cas9 deletion strategy that targets the majority of DMD patients restores dystrophin function in hiPSC-derived muscle cells","volume":"18","author":"Young","year":"2016","journal-title":"Cell stem cell"},{"issue":"1","key":"10.1016\/j.gendis.2019.12.007_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aap9004","article-title":"Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing","volume":"4","author":"Long","year":"2018","journal-title":"Sci Adv"},{"issue":"418","key":"10.1016\/j.gendis.2019.12.007_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan8081","article-title":"Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy","volume":"9","author":"Amoasii","year":"2017","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.gendis.2019.12.007_bib54","doi-asserted-by":"crossref","first-page":"eaav4324","DOI":"10.1126\/sciadv.aav4324","article-title":"CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells","volume":"5","author":"Min","year":"2019","journal-title":"Sci Adv"},{"issue":"6","key":"10.1016\/j.gendis.2019.12.007_bib55","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.ymthe.2018.03.018","article-title":"Functional rescue of dystrophin deficiency in mice caused by frameshift mutations using Campylobacter jejuni Cas9","volume":"26","author":"Koo","year":"2018","journal-title":"Mol Ther: J Am Soc Gene Ther"},{"issue":"6410","key":"10.1016\/j.gendis.2019.12.007_bib56","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.aau1549","article-title":"Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy","volume":"362","author":"Amoasii","year":"2018","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.gendis.2019.12.007_bib57","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/humu.20976","article-title":"Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD\u2013DMD database: a model of nationwide knowledgebase","volume":"30","author":"Tuffery-Giraud","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.gendis.2019.12.007_bib58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.omtn.2017.02.004","article-title":"Correction of the exon 2 duplication in DMD myoblasts by a single CRISPR\/Cas9 system","volume":"7","author":"Lattanzi","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10.1016\/j.gendis.2019.12.007_bib59","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ajhg.2015.11.012","article-title":"Spell checking nature: versatility of CRISPR\/Cas9 for developing treatments for inherited disorders","volume":"98","author":"Wojtal","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10.1016\/j.gendis.2019.12.007_bib60","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/jmg.30.9.728","article-title":"Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups","volume":"30","author":"Nicholson","year":"1993","journal-title":"J Med Genet"},{"issue":"6","key":"10.1016\/j.gendis.2019.12.007_bib61","first-page":"2484","article-title":"Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin\/utrophin double-knockout mice","volume":"27","author":"van Putten","year":"2013","journal-title":"FASEB (Fed Am Soc Exp Biol) J"},{"issue":"5","key":"10.1016\/j.gendis.2019.12.007_bib62","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","article-title":"Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression","volume":"152","author":"Qi","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2019.12.007_bib63","doi-asserted-by":"crossref","first-page":"e833","DOI":"10.1038\/nbt.2675","article-title":"CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering","volume":"31","author":"Mali","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.gendis.2019.12.007_bib64","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1038\/ng0598-79","article-title":"Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice","volume":"19","author":"Rafael","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.gendis.2019.12.007_bib65","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1038\/nrg3460","article-title":"Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches","volume":"14","author":"Fairclough","year":"2013","journal-title":"Nat Rev Genet"},{"issue":"7","key":"10.1016\/j.gendis.2019.12.007_bib66","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.cell.2017.10.025","article-title":"In\u00a0vivo target gene activation via CRISPR\/Cas9-Mediated trans-epigenetic modulation","volume":"171","author":"Liao","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2019.12.007_bib67","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.omtn.2016.11.004","article-title":"Increased expression of laminin subunit alpha 1 chain by dCas9-VP160","volume":"6","author":"Perrin","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"10.1016\/j.gendis.2019.12.007_bib68","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","article-title":"Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy","volume":"25","author":"Nelson","year":"2019","journal-title":"Nat Med"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304220300015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304220300015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:25:50Z","timestamp":1762449950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304220300015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2352304220300015"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2019.12.007","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promising therapeutic approaches using CRISPR\/Cas9 genome editing technology in the treatment of Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2019.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Chongqing Medical University. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}